CVRx — Third Quarter 2026 Earnings Summary

CVRx reported third-quarter 2026 total revenue of $13.8 million, a 6% decrease from the prior year period, driven by lower sales force productivity and payer challenges. The company expanded its U.S. active implanting centers to 262 and secured coverage policies from two major Medicare Advantage providers representing approximately 21% of enrollment. Net loss for the quarter was $14.2 million, or $0.52 per share, while cash and cash equivalents stood at $58.7 million as of September 30, 2026. For the full year 2026, CVRx revised its total revenue guidance to a range of $56.0 million to $57.0 million.